BRAINTREE, Mass. - Blood collection and processing systems maker Haemonetics Corp. boosted its fiscal 2009 outlook Friday after topping Wall Street's first-quarter expectations.
| HAE | 55.7 |
The company now expects profit for the year ending in March between $2.33 and $2.43 per share, excluding charges, up from prior guidance of $2.31 to $2.41 per share. Revenue is now expected to rise between 10 percent and 13 percent, up from between 8 percent and 11 percent.
The revenue guidance implies a boost to between $568 million and $583.5 million, up from guidance of between $557.8 million to $573.2 million.
Analysts expect profit of $2.36 per share on revenue of $565.6 million.
Shares rose $2.94, or 5.1 percent, to $61.03 in afternoon trading. The stock has traded between $47.13 and $64.29 over the past 52 weeks.
U.S. stocks were mixed on Thursday after retailers reported mostly disappointing sales while other big-name companies announced layoffs and Europ...
China markets opened lower on Tuesday morning as the investors' confidence hit by the signals that global recession are deepening.
The markets have spoken: risk aversion is still the name of the game and that was obvious since the beginning of the week.


Building your business and corporate credit for your small business.
Get your next web design project done with our los angeles web design team - Best web design with great price.
Baldwin Linguas:
Translations Interpreting Localization:
English French Portuguese Spanish